𝗗𝗼 𝘆𝗼𝘂 𝗰𝘂𝗿𝗿𝗲𝗻𝘁𝗹𝘆 𝗼𝗿 𝗵𝗮𝘃𝗲 𝘆𝗼𝘂 𝘁𝗮𝗸𝗲𝗻 𝗱𝗲𝘂𝗰𝗿𝗮𝘃𝗮𝗰𝗶𝘁𝗶𝗻𝗶𝗯 (𝗦𝗼𝘁𝘆𝗸𝘁𝘂™)? Psoriasis Australia is looking for patients to participate in a focus group who are currently taking or have previously taken or prescribed Deucravacitinib (Sotyktu) to tell you story about your experience of the medication in late April 2025. If you are one of the above drop us a DM and we will provide you with further information. We understand the importance of your time and, as such, you will remunerated for time spent at the focus group and on any pre-reading materials you may be required to read. Your confidentiality will be maintained throughout the process. (fb)

𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐏𝐥𝐚𝐪𝐮𝐞 𝐏𝐬𝐨𝐫𝐢𝐚𝐬𝐢𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐓𝐫𝐢𝐚𝐥 (𝟑𝟐 𝐖𝐄𝐄𝐊𝐒)⁣ ⁣ The Skin Health Institute in Melbourne, Victoria are recruiting participants for a Chronic Plaque Psoriasis Research Trial over 32 weeks.⁣ ⁣ Participants need to be an adult aged 18 years or older with a clinical diagnosis of moderate to severe plaque psoriasis more than 6 months ago. If you qualify to participate in the study you may receive either an investigational oral medication (active study drug), placebo, or an approved comparator medication.⁣ ⁣ To qualify you must:⁣ ⁣ Be 18 years or older;⁣ - Plaque psoriasis covering 10% or more of the body surface area (BSA);⁣ - Not have another form of psoriasis dominant other than plaque psoriasis; (fb)